Nmda Receptor Antagonists
NMDA Receptor Antagonists is a class of pharmacological agents that selectively inhibit the activity of N-methyl-D-aspartate (NMDA) receptors, thereby modulating glutamatergic neurotransmission implicated in central sensitization and chronic neuropathic pain.
5.3K
Publications
382.4K
Citations
16.6K
Authors
2.7K
Institutions
Publications per year
2017–2026
423
5.3K
Blockade of NMDA Receptors and Apoptotic Neurodegeneration in the Developing Brain
Chrysanthy Ikonomidou, Friederike Bosch, Michael Miksa et al. · Science · 1999 · 2.1K citations
Memantine in Moderate-to-Severe Alzheimer's Disease
Barry Reisberg, Rachelle S. Doody, Albrecht Stöffler et al. · New England Journal of Medicine · 2003 · 2K citations · Full text
Medicine, Neuroscience, Pharmacology +16
1–5 of 5.3K
16.6K
29
h-index
23
h-index
21
h-index
First Pavlov State Medical University of St. Petersburg, Russia
27 publications · 886 citations
20
h-index
20
h-index
1–5 of 16.6K
2.7K
Yale University
New Haven, United States
52 h-index
255 publications
50.7K citations
National Institutes of Health
Bethesda, United States
46 h-index
220 publications
26.1K citations
Inserm
Paris, France
41 h-index
292 publications
21.8K citations

Washington University in St. Louis
St Louis, United States
39 h-index
180 publications
27.9K citations
University College London
London, United Kingdom
38 h-index
145 publications
32.3K citations
University of California, San Francisco
San Francisco, United States
38 h-index
153 publications
13.9K citations

Karolinska Institutet
Stockholm, Sweden
37 h-index
160 publications
9.4K citations
University of Pittsburgh
Pittsburgh, United States
36 h-index
128 publications
13.5K citations
1–8 of 2.7K
290 publications · 56.3K citations
135
h-index
176 publications · 14K citations
71
h-index
JNC · 204 publications · 15.8K citations
70
h-index
119 publications · 13.8K citations
66
h-index
186 publications · 10K citations
56
h-index
1–5